Drug Shortage Report for SELEGILINE

Last updated on 2019-07-19 History
Report ID 87064
Drug Identification Number 02230641
Brand name APO-SELEGILINE
Common or Proper name SELEGILINE
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) SELEGILINE HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code N04BD
ATC description DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-17
Estimated end date 2019-07-24
Actual end date 2019-07-18
Shortage status Resolved
Updated date 2019-07-19
Company comments
Health Canada comments
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-07-19 French Compare
v3 2019-07-19 English Compare
v2 2019-06-19 French Compare
v1 2019-06-19 English Compare